Celon Pharma SA (CLN) — Free Cash Flow Generation Index

Latest as of December 2025: 0.28x

Celon Pharma SA (CLN) has a Free Cash Flow Generation Index of 0.28x as of December 2025. Free cash flow of zł10.16 Million represents 0% of operating cash flow (zł36.63 Million). Explore CLN capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.28x
Free Cash Flow / Operating CF

Free Cash Flow

zł10.16 Million
PLN

Operating Cash Flow

zł36.63 Million
PLN

Capital Expenditures

zł26.48 Million
PLN

Celon Pharma SA Free Cash Flow Generation Index (2012–2025)

Historical FCF Generation Index trend for Celon Pharma SA across 10 annual periods. For the full cash flow conversion analysis, see Celon Pharma SA (CLN) cash conversion ratio.

Annual Free Cash Flow Generation for Celon Pharma SA (2012–2025)

Year-by-year Free Cash Flow Generation Index for Celon Pharma SA. Check CLN capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (PLN) Operating CF Capital Expenditures YoY Change
2025 -1.28x zł-30.57 Million zł23.86 Million zł54.44 Million ▼ -2265.5%
2021 0.06x zł2.60 Million zł43.95 Million zł41.35 Million ▲ +114.8%
2020 -0.40x zł-28.26 Million zł70.90 Million zł99.16 Million ▲ +71.3%
2018 -1.39x zł-39.22 Million zł28.24 Million zł67.46 Million ▼ -482.0%
2017 -0.24x zł-6.04 Million zł25.30 Million zł31.34 Million ▼ -668.4%
2016 -0.03x zł-641.17K zł20.65 Million zł21.29 Million ▼ -121.7%
2015 0.14x zł7.51 Million zł52.37 Million zł44.86 Million ▲ +92.7%
2014 0.07x zł1.81 Million zł24.36 Million zł22.55 Million ▼ -77.6%
2013 0.33x zł2.81 Million zł8.45 Million zł5.64 Million ▼ -49.8%
2012 0.66x zł8.52 Million zł12.87 Million zł4.34 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).